Predicting severe COVID-19: attack of the killer (T) cells

0

A team of researchers has identified the first biomarker to reliably predict patients at risk of developing a severe case of COVID-19.

In severe cases of COVID-19, the body’s immune system over-reacts to the virus by producing cytokines at a much higher rate, leading to a ‘cytokine storm’ and mass inflammation. Understanding this immune response triggered by COVID-19 is vital to understanding and predicting when a patient may suffer a severe case.

READ MORE ON BIOANALYSIS ZONE NOW

Share:

Leave A Comment